Terms: = Lung cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
440 results:
1. foxp3: A Player of Immunogenetic Architecture in lung cancer.
Ziółkowska-Suchanek I; Żurawek M
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674427
[TBL] [Abstract] [Full Text] [Related]
2. The Expression and Prognostic Significance of ICOS in NSCLC Integrated Pan-cancer and Multi-Omics Analyses.
Chen M; Yan X; Hong B; Xiao Y; Qian Y
Int J Med Sci; 2024; 21(5):795-808. PubMed ID: 38616999
[No Abstract] [Full Text] [Related]
3. Dynamic Changes of the Gut Microbiota and Its Functional Metagenomic Potential during the Development of Non-Small Cell lung cancer.
Feng C; Li N; Gao G; He Q; Kwok LY; Zhang H
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612577
[TBL] [Abstract] [Full Text] [Related]
4. PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell lung cancer.
Gurevičienė G; Matulionė J; Poškienė L; Miliauskas S; Žemaitis M
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541208
[No Abstract] [Full Text] [Related]
5. Role of CD38 in anti-tumor immunity of small cell lung cancer.
Taniguchi H; Chavan SS; Chow A; Chan JM; Mukae H; Rudin CM; Sen T
Front Immunol; 2024; 15():1348982. PubMed ID: 38533509
[TBL] [Abstract] [Full Text] [Related]
6. HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma.
Liu L; Zhang Z; Jiang C; Zhu Y; Han R; Wu L; Xu Y
Aging (Albany NY); 2024 Mar; 16(5):4841-4861. PubMed ID: 38446596
[TBL] [Abstract] [Full Text] [Related]
7. Mediator complex subunit 1 architects a tumorigenic Treg cell program independent of inflammation.
Chaudhuri SM; Weinberg SE; Wang D; Yalom LK; Montauti E; Iyer R; Tang AY; Torres Acosta MA; Shen J; Mani NL; Wang S; Liu K; Lu W; Bui TM; Manzanares LD; Dehghani Z; Wai CM; Gao B; Wei J; Yue F; Cui W; Singer BD; Sumagin R; Zhang Y; Fang D
Cell Rep Med; 2024 Mar; 5(3):101441. PubMed ID: 38428427
[TBL] [Abstract] [Full Text] [Related]
8. Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer.
Shibaki R; Fujimoto D; Nozawa T; Sano A; Kitamura Y; Fukuoka J; Sato Y; Kijima T; Matsumoto H; Yokoyama T; Miura S; Hata A; Tamiya M; Taniguchi Y; Sugisaka J; Furuya N; Tanaka H; Yamamoto N; Koh Y; Akamatsu H
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38360040
[TBL] [Abstract] [Full Text] [Related]
9. Tumor microenvironment(TME) and single-source dual-energy CT(ssDECT) on assessment of inconformity between RECIST1.1 and pathological remission in neoadjuvant immunotherapy of NSCLC.
Sun C; Ma X; Meng F; Chen X; Wang X; Sun W; Xu Y; He H; Zhang H; Ma K
Neoplasia; 2024 Apr; 50():100977. PubMed ID: 38354688
[TBL] [Abstract] [Full Text] [Related]
10. Association of Baseline Tumor-Specific Neoantigens and CD8
Kerepesi C; Abushukair HM; Ricciuti B; Nassar AH; Adib E; Alessi JV; Pecci F; Rakaee M; Fadlullah MZH; Tőkés AM; Rodig SJ; Awad MM; Tan AC; Bakacs T; Naqash AR
JCO Precis Oncol; 2024 Feb; 8():e2300439. PubMed ID: 38330262
[TBL] [Abstract] [Full Text] [Related]
11. Characterization of the MT-2 Treg-like cell line in the presence and absence of forkhead box P3 (foxp3).
McCullough MJ; Tune MK; Cabrera JC; Torres-Castillo J; He M; Feng Y; Doerschuk CM; Dang H; Beltran AS; Hagan RS; Mock JR
Immunol Cell Biol; 2024 Mar; 102(3):211-224. PubMed ID: 38288547
[TBL] [Abstract] [Full Text] [Related]
12. Amplifying T cell-mediated antitumor immune responses in nonsmall cell lung cancer through photodynamic therapy and anti-PD1.
Gong B; Wang L; Zhang H; Wang Q; Li W
Cell Biochem Funct; 2024 Jan; 42(1):e3925. PubMed ID: 38269509
[TBL] [Abstract] [Full Text] [Related]
13. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
[TBL] [Abstract] [Full Text] [Related]
15. Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer.
Mouri A; Kaira K; Yamaguchi O; Hashimoto K; Miura Y; Shiono A; Kawasaki T; Kobayashi K; Imai H; Kagamu H
Int J Clin Oncol; 2024 Feb; 29(2):124-133. PubMed ID: 38160406
[TBL] [Abstract] [Full Text] [Related]
16. Association of Wiskott-Aldrich syndrome protein (WASp) in epigenetic regulation of B cell differentiation in non-small-cell lung cancer (NSCLC).
Chandnani N; Mandal A; Gupta I; Mukherjee O; Rakshit S; Shanmugam G; George M; Sarkar K
Med Oncol; 2023 Dec; 41(1):28. PubMed ID: 38146020
[TBL] [Abstract] [Full Text] [Related]
17. Imbalance of Circulating Follicular Regulatory and Follicular Helper T Cell Subpopulations Is Associated with Disease Progression and Serum CYFRA 21-1 Levels in Patients with Non-small Cell lung cancer.
Liu TC; Zheng MH; Zeng XY; Kang R; Bahabayi A; Tuerhanbayi B; Lu SS; Liu C
Curr Med Sci; 2024 Feb; 44(1):102-109. PubMed ID: 38079054
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells.
Zhang K; Sun T; Li W; Guo Y; Li A; Hsieh M; Wang J; Wu J; Arvanitis L; Raz DJ
Cell Commun Signal; 2023 Nov; 21(1):319. PubMed ID: 37946202
[TBL] [Abstract] [Full Text] [Related]
19. Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.
Alessi JV; Price A; Richards AL; Ricciuti B; Wang X; Elkrief A; Pecci F; Di Federico A; Gandhi MM; Lebow ES; Santos PMG; Thor M; Rimner A; Schoenfeld AJ; Chaft JE; Johnson BE; Gomez DR; Awad MM; Shaverdian N
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37914383
[TBL] [Abstract] [Full Text] [Related]
20. Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective stud.
Voong KR; Illei PB; Presson B; Singh D; Zeng Z; Lanis M; Hales RK; Hu C; Tran PT; Georgiades C; Lin CT; Thiboutout J; Brahmer JR; Forde PM; Naidoo J; Anagnostou V; Smith KN
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37793854
[TBL] [Abstract] [Full Text] [Related]
[Next]
